Used by over 30 global pharma companies across 20+ therapeutic areas, reducing trial costs by 50%, shortening duration by 40%, and boosting success rates by over 30%.
Organizations Involved
30 global pharma companies
Founders
Raviv Pryluk
Company Description
PhaseV provides AI-driven solutions for efficient clinical development and operations.